NX PRENATAL

NX Prenatal Inc. is a private US based molecular diagnostics company with locations in Louisville, KY and Houston, TX. NX Prenatal is developing diagnostic assays for adverse pregnancy conditions such as preterm birth. It employs the proprietary NeXosome® platform, which enables advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation. We are planning the US launch of the NeXosome Preterm Birth Risk Assay, which detects a new library of biomarkers for prenatal risk assessment as early as 10 weeks gestation. This technology may provide physicians an ideal opportunity to intervene in a timely manner with protocols for at-risk pregnancies in an attempt to reduce the likelihood of a preterm birth or minimize the complications that can arise for both the child and the mother... NX Prenatal is developing early warning blood tests for pregnant moms to assess the risk for preterm birth and other adverse pregnancy..

Also known as: NX Prenatal Inc.

Primary location: Louisville United States